[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Edgewise Therapeutics, Inc. Common Stock
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% no change
6 Months: XXX% +31%
1 Year: XXX% +10%
1-Year High: XXX% on 2025-01-29
1-Year Low: XX% on 2025-03-21
Most Supportive Themes
- Positive Data and Presentations: (45%) Edgewise Therapeutics is presenting positive data on Sevasemten for Becker and Duchenne Muscular Dystrophies, with positive commentary from analysts and investors.
- Analyst Coverage and Ratings: (35%) Stifel and H.C. Wainwright have reiterated positive ratings and price targets for Edgewise Therapeutics, citing positive data and potential.
- Mentions in Biotech Watchlists: (10%) Edgewise Therapeutics is included in biotech stock catalyst watchlists, indicating upcoming data readouts and potential catalysts.
Most Critical Themes
- Market Volatility: (10%) The stock price has shown volatility, with recent fluctuations and a significant drop from its 1-year high.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XX | XX% | XXX | XX% | X | X% |
| Total | XX | XX% | XXX | XX% | X | X% |